Comparing Detection Rates: Dual vs Triple vs Quad Marker Tests - LabDecoded

Dual vs Triple vs Quad Marker Tests

Clear, evidence-based comparison of first-trimester Dual Marker (combined with NT) versus second-trimester Triple and Quad Marker tests — markers measured, real detection rates, strengths, limitations, and what a positive result actually means today.

Maternal Serum Screening Detection Rates 1st vs 2nd Trimester

Quick takeaway: First-trimester combined screening (Dual markers + nuchal translucency) generally offers the highest detection among traditional serum screens and gives earlier results. The Quad screen is clearly better than the Triple screen for Down syndrome detection. All three are screening tests only — positive results require follow-up with NIPT or diagnostic testing (CVS/amniocentesis). In 2026, NIPT has largely replaced these tests as the preferred aneuploidy screen in many settings.

📋 Contents

1. Overview of the three tests
2. Side-by-side comparison table
3. Accurate detection rates explained
4. Why the numbers differ (the science)
5. What to do after a positive screen
6. How these tests compare with NIPT today
7. Frequently asked questions
8. Bottom line & practical recommendations

1. Overview of the Three Tests

Dual Marker Test (First Trimester)

Usually performed between 11–13+6 weeks. It measures two biochemical markers — free β-hCG and PAPP-A — and is almost always combined with nuchal translucency (NT) ultrasound measurement. This combination is called first-trimester combined screening and is the most accurate of the traditional serum-based options when NT is included.

Triple Marker Test (Second Trimester)

Performed between 15–20 weeks (ideally 16–18). Measures three markers: AFP, total hCG, and unconjugated estriol (uE3). It can also screen for open neural tube defects via AFP.

Quad Marker Test (Second Trimester)

Same timing as the Triple test. Adds a fourth marker — Inhibin-A — to the triple panel. This addition improves detection of Down syndrome while retaining the ability to screen for neural tube defects.

2. Side-by-Side Comparison

Feature	Dual Marker + NT (1st Trimester Combined)	Triple Marker (2nd Trimester)	Quad Marker (2nd Trimester)
Timing	11–13+6 weeks	15–20 weeks	15–20 weeks
Markers	Free β-hCG + PAPP-A + NT ultrasound	AFP + hCG + uE3	AFP + hCG + uE3 + Inhibin-A
Primary targets	Trisomy 21, Trisomy 18	Trisomy 21, Trisomy 18, Neural tube defects	Trisomy 21, Trisomy 18, Neural tube defects
Detection rate for Down syndrome	~85–90% (with NT)	~65–75%	~80–85%
Typical false-positive rate	~5%	~5%	~5%
Neural tube defect screening	No (AFP not measured)	Yes (via AFP)	Yes (via AFP)
Key advantage	Earlier results + higher detection when NT is included	Includes NTD screening; widely available	Better Down syndrome detection than Triple + NTD screening
Main limitation	Requires high-quality NT measurement	Lower detection than combined first-trimester or Quad	Still only a screening test; later timing

Detection rates are approximate and assume a ~5% screen-positive rate. Actual performance varies by laboratory protocol, population, and accuracy of gestational dating.

3. Accurate Detection Rates Explained

• First-trimester combined screening (Dual + NT): Typically detects 85–90% of Down syndrome cases at a 5% false-positive rate — the best performance among traditional serum screens.
• Triple screen: Detects roughly 65–75% of Down syndrome cases.
• Quad screen: Detects approximately 80–85% of Down syndrome cases — a clear improvement over the Triple screen thanks to the addition of Inhibin-A.

For Trisomy 18, detection is generally lower across all three tests. Open neural tube defect detection (via AFP in Triple/Quad) is around 80–85% for open spina bifida and higher for anencephaly.

4. Why the Detection Rates Differ

The first-trimester combined test captures early placental and fetal changes (especially nuchal translucency) and therefore performs better for common aneuploidies when done well.

In the second trimester, adding Inhibin-A improves Down syndrome detection because levels of this placental hormone tend to be higher in affected pregnancies. This is why the Quad screen consistently outperforms the Triple screen.

All results are reported as Multiples of the Median (MoM) and adjusted for maternal age, weight, ethnicity, diabetes status, and exact gestational age. Accurate ultrasound dating is essential — even small dating errors can shift MoM values and change the final risk.

5. What to Do After a Positive (High-Risk) Screen

1. Remember: a positive screen means increased probability, not a diagnosis.
2. Discuss the result with your obstetrician or a genetic counselor.
3. Most centers now offer NIPT (cell-free DNA) as the next step because of its much higher sensitivity and lower false-positive rate for common trisomies.
4. If NIPT is also high-risk, or if ultrasound shows structural anomalies, diagnostic testing (CVS or amniocentesis) is recommended for confirmation.
5. A detailed anatomy ultrasound should be performed regardless.

Never make irreversible decisions based solely on a serum screening result.

6. How These Tests Compare with NIPT in 2026

NIPT (cell-free DNA testing) detects >99% of Down syndrome cases with a false-positive rate usually under 0.5%. Because of this superior performance, major guidelines (ACOG/SMFM) now recommend offering NIPT as a primary screening option to all pregnant patients.

Dual, Triple, and Quad screens remain useful in settings where NIPT is not available or not covered, or when neural tube defect screening via AFP is specifically desired. Many patients who receive a high-risk traditional screen are now offered NIPT as the immediate next step rather than going straight to invasive testing.

7. Frequently Asked Questions

Is the Quad screen better than the Triple screen?

Yes. Adding Inhibin-A improves detection of Down syndrome while keeping the ability to screen for neural tube defects. Most laboratories prefer the Quad over the Triple when second-trimester screening is chosen.

Should I choose first-trimester Dual + NT or wait for the Quad?

If available, first-trimester combined screening is generally preferred because it gives earlier results and higher detection rates for common aneuploidies. The Quad remains a good option if you present later or if first-trimester screening was missed.

Are any of these tests diagnostic?

No. Dual, Triple, and Quad are all screening tests. A high-risk result must be followed by further evaluation (usually NIPT and/or diagnostic testing).

Can these tests replace NIPT?

No. NIPT has significantly higher detection and lower false-positive rates for the common trisomies. Traditional marker tests still have a role, especially for neural tube defect screening or when NIPT is inaccessible.

8. Bottom Line & Practical Recommendations

• First-trimester combined screening (Dual markers + NT) offers the best traditional detection rates and earliest results.
• Quad screen is clearly superior to Triple screen for Down syndrome detection.
• All three remain screening tests only.
• In 2026, NIPT is the preferred primary aneuploidy screen for most patients when available.
• Any positive traditional screen should prompt discussion of NIPT and/or diagnostic testing plus detailed ultrasound.

About LabDecoded

LabDecoded provides clear, evidence-based explanations of laboratory and prenatal screening tests. Content is aligned with current clinical understanding of maternal serum screening performance.

Updated: 2026